The journal has a particular focus on women's issues in the context of the U.S. health care delivery system and policymaking processes, although it invites submissions addressing women's health care issues in global context if relevant to North American readers. As the official journal of the Jacobs Institute of Women's Health, it builds on a history of valuing methodologically rigorous investigation as a basis for improving the quality of health care for women and the health of women across the lifespan.
The journal seeks to inform health services researchers, social scientists, health care and public health professionals, and policymakers and to engage readers in the perspectives of multiple disciplines relevant to the study of women's health.Please note that we do not accept for review clinical case reports or standard literature reviews. Systematic literature reviews that include data syntheses (rather than just summaries of published work), and translational and implementation research studies are welcome.
The editorial board is also interested in empirical, methodological, and commentary pieces focused on the evaluation of sex and gender differences, with an emphasis on the reporting of stratified results over statistical adjustment.All manuscripts are subject to peer-review under the direction of the editors. Published manuscripts are abstracted and indexed in leading services, including Cumulative Index to Nursing and Allied Health Literature, EMBASE/Excerpta Medica, Index Medicus, ISI's Current Contents/Social & Behavioral Sciences Research Alert and Social SciSearch, Sociological Abstracts, and Studies on Women Abstracts. Unsolicited manuscripts are invited that address women's health issues relating to the mission of the journal. Further information is available at http://www.jiwh.org. The Journal is available online at http://whijournal.com and on www.ScienceDirect.com. Ethics in Publishing
For information on Ethics in publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics and http://www.elsevier.com/journal-authors/ethics. Ethical Approval of Studies and Informed Consent: If applicable, all manuscripts reporting data from studies involving human participants should include a statement that the research protocol was approved by the relevant institutional review boards or ethics committees. State in the Methods section the manner in which informed consent was obtained from the study participants (i.e., oral or written). For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki of 1975 and as revised in 2000, should be followed. This requirement is in compliance with "Protection of Human Subjects and Animals in Research" described by the International Committee of Medical Journal Editors (http://www.icmje.org/#protect).
Editorial policy for ethics reviews in manuscripts reporting quality improvement studiesThe editors of Women's Health Issues encourage submission of manuscripts that assess the impact of various quality improvement initiatives in health care. These initiatives may be at the system, organization, clinic, or provider levels. Often the evaluation of these initiatives involves collection of data from patients, health care providers, staff, trainees, or others. Policies and practices with respect to ethics reviews for quality improvement projects vary, and institutional policies are not consistent.
Accordingly, the editorial board of Women's Health Issues has adopted the following policy for manuscripts based on quality improvement projects that are submitted to the journal for possible publication.1. When the manuscript is based on quality improvement activities conducted at an academic institution or a health care organization with an Institutional Review Board, or when the author of the manuscript is employed at an academic institution or a health care organization with an IRB, the author of the manuscript is required to provide a statement to the effect that the study was or was not reviewed by the IRB. If the study was not reviewed by the IRB, the reason must be stated. If the study met the IRB's criteria for exemption or if the study was determined to not constitute research, then that should be explicitly stated.
2. When the manuscript is based on quality improvement activities conducted at an academic institution or a health care organization without an IRB or at an academic institution or a health care organization that does not regard quality improvement efforts as research involving human subjects, then the authors are required to provide a statement to that effect.The editors reserve the right to contact the authors to clarify the situation or to confirm that ethical practices were used in the conduct of the study.
Whether to proceed to peer review is at the Editor's discretion. Inquiries about this policy may be directed to the Editor-in-Chief of Women's Health Issues.Conflict of Interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. See also http://www.elsevier.com/conflictsofinterest.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see http://www.elsevier.com/postingpolicy), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder. Further to this policy, Each and every author must attest to the following statement: "I certify that this material has not been published previously and is not under consideration by another journal. I further certify that I have had substantive involvement in the preparation of this manuscript and am fully familiar with its content."
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
For open access articles: Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' (more information). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Funding body agreements and policies
Elsevier has established a number of agreements with funding bodies which allow authors to comply with their funder's open access policies. Some funding bodies will reimburse the author for the Open Access Publication Fee. Details of existing agreements are available online.
For all reports (regardless of funding source) containing original data, at least one (1) named author (e.g., the principal investigator) who is independent of any funder or sponsor should indicate that she or he "had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis." This exact statement should be included in the Acknowledgments section on the Title Page of the manuscript. Modified statements or generic statements indicating that all authors had such access are not acceptable.
These requirements are consistent with "Potential Conflicts of Interest Related to Project Support" described by the International Committee of Medical Journal Editors (http://www.icmje.org/#conflicts).Elsevier will send to PubMed Central the author's manuscript on behalf of authors reporting research supported by an NIH grant. The author manuscript reflects any author-agreed changes made in response to peer-review comments. Elsevier will authorize its public access posting on PubMed Central 12 months after final publication. Authors will receive further correspondence from PubMed Central after the manuscript is deposited.
Green open access
Authors can share their research in a variety of different ways and Elsevier has a number of green open access options available. We recommend authors see our green open access page for further information. Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications. Embargo period: For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before an article becomes freely available to the public. This is the embargo period and it begins from the date the article is formally published online in its final and fully citable form. Find out more.
This journal has an embargo period of 12 months.
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Please visit "Language Editing Checklist" online at External link http://www.elsevier.com/journal-authors/editing-checklist to assist you in preparing your manuscript in its best possible form. Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop http://webshop.elsevier.com/languageediting/ or visit our customer support site http://support.elsevier.com/ for more information.
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Please submit your article via http://ees.elsevier.com/whi.
Please submit, with the manuscript, the names, addresses and e-mail addresses of three potential referees. Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.
Commentaries: Commentaries should contain no more than 2,000 words and should present a novel argument about a topic affecting women's health. Commentary manuscripts do not need to follow the structure of full-length articles (e.g., they do not require abstracts or the sections listed under "Article Structure" below). The argument presented, however, must be supported with references.Each submission from either of these categories must include a Cover Letter and a Title Page as well as a blinded Manuscript without Author Details. If a manuscript is revised and re-submitted, the revision must be accompanied by a Response to Reviewers and by an Author Descriptions file if this was not submitted with the original manuscript.
Systematic Literature Reviews Systematic literature reviews that include data syntheses (rather than just summaries of published work) are welcome. For examples of what constitutes a systematic literature review, please visit the Cochrane Collaborative at http://www.cochrane.org/about-us/evidence-based-health-care. Please note that we do not accept for review clinical case reports or standard literature reviews.Policy Matters We invite authors to submit scholarly, thoughtful, and timely policy analyses related to various issues affecting women's health. These could include, for example:
- Policy implications of proposed legislation, regulations, judicial decisions at the federal, state, and local levels as they may affect women's health;
- Policy implications of current and future developments in programs integral to women's health (e.g., Medicaid, Medicare, community health, Healthy Start, WIC, family planning, public health, and private sector insurance coverage);
- Scholarly policy analyses of health and social issues affecting women's health from a historical perspective, e.g., the effects of delinking Medicaid from welfare and subsequent reproductive health choices, or the effects of state and national health reform efforts on women's health; and,
- Scholarly policy analyses that contribute to our understanding of how effective policy actions can improve the scope and quality of women's health care services and the organization, financing, and delivery of these services.
"Policy Matters" submissions may contain recommendations for "next steps," however a key peer review criterion will be the extent to which such recommendations are supported by the rigor and comprehensiveness of the supporting policy analysis. "Policy Matters" manuscripts should not exceed 3,000 words - charts and graphs are encouraged when appropriate. Please note in your submission cover letter that you are submitting to the "Policy Matters" category.The journal continues to give priority to scholarly health services research articles that report the results of original research and that improve understanding of how social, health care, and policy factors relate to women's health. We seek in particular research articles and commentaries that:
- Contribute to a better understanding of gender-based health services research and policy; and
- Document applied integration and implementation strategies that translate new clinical, health services, and health policy research findings into women's health care practice and policy
This journal uses double-blind review, which means the identities of the authors are concealed from the reviewers, and vice versa. More information is available on our website. To facilitate this, please include the following separately:
Title page (with author details): This should include the title, authors' names and affiliations, and a complete address for the corresponding author including an e-mail address.
Blinded manuscript (no author details): The main body of the paper (including the references, figures, tables and any acknowledgements) should not include any identifying information, such as the authors' names or affiliations.
Manuscripts should be double-spaced, use fonts of no smaller than 12 points, include page numbers, and contain no identifying information. Please blind the name of your institution (if mentioned when describing IRB approval, study location, etc.) and any references that are identified as being previous work by the same author(s). Material and methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described. Discussion
This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.
Implications for Practice and/or Policy
All manuscripts must contain a section entitled, "Implications for Practice and/or Policy." This section should address what practical lessons practitioners and/or policymakers can learn and potentially implement to improve outcomes. The manuscript text must not include any identifying author details.
The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that phone numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.
• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
• Funding statement. A statement of any funding sources for the work reported in the manuscript, with disclosure of any financial conflicts of interest involving any of the co-authors.
•Acknowledgments. As needed.
The Author Descriptions page must contain short (< 41 words) descriptions of the affiliations and research interests or areas of expertise for each author for publication with the manuscript if accepted for publication.
A structured abstract, by means of appropriate headings, should provide the context or background for the research and should state its purpose, basic procedures (observational and analytical methods), main findings (giving specific effect sizes and their statistical significance, if possible), and principal conclusions (including implications for practice and/or policy). It should emphasize new and important aspects of the study or observations.Abstract should be no longer than 250 words.
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.
List funding sources in this standard way to facilitate compliance to funder's requirements:
Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa].It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding.
If no funding has been provided for the research, please include the following sentence:This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Math formulae
Please submit math equations as editable text and not as images. Present simple formulae in line with normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively any equations that have to be displayed separately from the text (if referred to explicitly in the text).
Footnotes should be used sparingly. Number them consecutively throughout the article. Many word processors can build footnotes into the text, and this feature may be used. Otherwise, please indicate the position of footnotes in the text and list the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.
• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or use fonts that look similar.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the published version.
• Submit each illustration as a separate file.
A detailed guide on electronic artwork is available.
You are urged to visit this site; some excerpts from the detailed information are given here.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is' in the native document format.
Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please 'Save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of 500 dpi.
Please do not:
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colors;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF)or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites). For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Please submit tables as editable text and not as images. Tables can be placed either next to the relevant text in the article, or on separate page(s) at the end. Number tables consecutively in accordance with their appearance in the text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules and shading in table cells. Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted for publication.
Increased discoverability of research and high quality peer review are ensured by online links to the sources cited. In order to allow us to create links to abstracting and indexing services, such as Scopus, CrossRef and PubMed, please ensure that data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent link creation. When copying references, please be careful as they may already contain errors. Use of the DOI is encouraged.
As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article. Reference management software
Most Elsevier journals have their reference template available in many of the most popular reference management software products. These include all products that support Citation Style Language styles, such as Mendeley and Zotero, as well as EndNote. Using the word processor plug-ins from these products, authors only need to select the appropriate journal template when preparing their article, after which citations and bibliographies will be automatically formatted in the journal's style. If no template is yet available for this journal, please follow the format of the sample references and citations as shown in this Guide.
Users of Mendeley Desktop can easily install the reference style for this journal by clicking the following link:
When preparing your manuscript, you will then be able to select this style using the Mendeley plug-ins for Microsoft Word or LibreOffice.
Text: Citations in the text should follow the referencing style used by the American Psychological Association. You are referred to the Publication Manual of the American Psychological Association, Sixth Edition, ISBN 978-1-4338-0561-5, copies of which may be ordered online or APA Order Dept., P.O.B. 2710, Hyattsville, MD 20784, USA or APA, 3 Henrietta Street, London, WC3E 8LU, UK.
List: references should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified by the letters 'a', 'b', 'c', etc., placed after the year of publication.
Reference to a journal publication:
Van der Geer, J., Hanraads, J. A. J., & Lupton, R. A. (2010). The art of writing a scientific article. Journal of Scientific Communications, 163, 51–59.
Reference to a book:
Strunk, W., Jr., & White, E. B. (2000). The elements of style. (4th ed.). New York: Longman, (Chapter 4).
Reference to a chapter in an edited book:
Mettam, G. R., & Adams, L. B. (2009). How to prepare an electronic version of your article. In B. S. Jones, & R. Z. Smith (Eds.), Introduction to the electronic age (pp. 281–304). New York: E-Publishing Inc.
Reference to a website:
Cancer Research UK. Cancer statistics reports for the UK. (2003). http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/ Accessed 13.03.03.
Reference to a dataset:
[dataset] Oguro, M., Imahiro, S., Saito, S., Nakashizuka, T. (2015). Mortality data for Japanese oak wilt disease and surrounding forest compositions. Mendeley Data, v1. https://doi.org/10.17632/xwj98nb39r.1.
Journal names should be abbreviated according to the List of Title Word Abbreviations.
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include links to these within the body of the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file formats with a preferred maximum size of 150 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect. Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages. Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content.
If you have made your research data available in a data repository, you can link your article directly to the dataset. Elsevier collaborates with a number of repositories to link articles on ScienceDirect with relevant repositories, giving readers access to underlying data that give them a better understanding of the research described.
There are different ways to link your datasets to your article. When available, you can directly link your dataset to your article by providing the relevant information in the submission system. For more information, visit the database linking page.For supported data repositories a repository banner will automatically appear next to your published article on ScienceDirect.
In addition, you can link to relevant data or entities through identifiers within the text of your manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; CCDC: 734053; PDB: 1XFN).Interactive plots
This journal enables you to show an Interactive Plot with your article by simply submitting a data file. Full instructions.
The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
• Phone numbers
All necessary files have been uploaded, and contain:
• All figure captions
• All tables (including title, description, footnotes)
• Manuscript has been 'spell-checked' and 'grammar-checked'
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• For any further information please visit our customer support site at http://support.elsevier.com. Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download the free Adobe Reader, version 9 (or higher). Instructions on how to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and scan the pages and return via e-mail. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. It is important to ensure that all corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility.
The corresponding author will, at no cost, receive a customized Share Link providing 50 days free access to the final published version of the article on ScienceDirect. The Share Link can be used for sharing the article via any communication channel, including email and social media. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's Webshop. Corresponding authors who have published their article open access do not receive a Share Link as their final published version of the article is available open access on ScienceDirect and can be shared through the article DOI link.
Visit the Elsevier Support Center to find the answers you need. Here you will find everything from Frequently Asked Questions to ways to get in touch.
You can also check the status of your submitted article or find out when your accepted article will be published.